Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD M&A Activity 2023

Nov 7, 2023

2543_rns_2023-11-07_3fc12ba1-6c60-4e5c-a315-0549a88affba.pdf

M&A Activity

Open in viewer

Opens in your device viewer

Current report №196/2023 Dated November 7, 2023

NOTIFICATION

"Sopharma" AD (the Company) notifies that the Serbian Commission for Protection of Competition has authorized Sopharma AD to acquire the manufacturer Pharmanova in stages. The deal will take place in several stages, starting with the acquisition of 25% of the company's capital.

Ognian Donev